Sort by:
AZHB 2660House
Health Boards — Licensure Decisions and Investigation
Senate Engrossed; Pending GovernorHigh RiskPharmacy Operations
Apr 14, 2026
AZSB 1458Senate
Pharmacy Board — Civil Penalties and PBM Steering
Pending Governor (Signing Moratorium)High RiskPharmacy Operations
Apr 13, 2026
AZHB 2444House
Pharmacists — Independent Testing and Treatment (Carryover)
Pending Governor (Signing Moratorium)High RiskScope of Practice
Apr 13, 2026
AZSB 1188Senate
Approved Medications — Scheduling and Prescription Authority
Pending Governor (Signing Moratorium)Medium RiskControlled Substances
Apr 13, 2026
KYHB 387House
Veterinary Controlled Substances Prescribing Council
Delivered to Governor (Apr 1)Medium RiskControlled Substances
Apr 1, 2026
KYHB 676House
Statewide Health Data Utility Study
Delivered to Governor (Apr 1)Medium RiskPharmacy Operations
Apr 1, 2026
AZSB 1713Senate
AHCCCS — Procurement and Contracting
Passed Senate; House Appropriations DPA/SEMedium RiskInsurance / Coverage
Apr 1, 2026
AZHB 2732House
Pharmacy Board — Continuation
Passed House 43-11; Senate HHSHigh RiskOmnibus / Technical
Apr 1, 2026
ILHB 1272House
Wholesale Prescription Drug Importation Program Act
Re-referred to Rules Committee (Rule 19(a))Medium RiskDrug Importation
Mar 27, 2026
ILHB 4065House
340B Grantee Contract Pharmacy Access Act
Re-referred to Rules Committee (Rule 19(a))Medium Risk340B Program
Mar 27, 2026
ILHB 4954House
340B Drug Pricing Program Reporting Act (House)
Re-referred to Rules Committee (Rule 19(a))Low Risk340B Program
Mar 27, 2026
ILSB 66Senate
Health Care Availability and Access Board Act
Assigned to Senate Executive CommitteeHigh RiskDrug Pricing
Mar 27, 2026
ILSB 3521Senate
Controlled Substances — Prescriber/Dispenser System (Senate)
Assigned to Licensed Activities CommitteeLow RiskControlled Substances
Mar 27, 2026
KYSB 116Senate
Physician Assistant Prescribing Authority
Passed House 90-1; Returned to Senate RulesHigh RiskScope of Practice
Mar 27, 2026
KYHB 280House
Health Care — APRN & School Medication Access
Posted for Concurrence in Senate Committee SubstituteMedium RiskScope of Practice
Mar 27, 2026
ILHB 2371House
340B Contract Pharmacy Protections
House Concurrence — Senate Amendments 1, 2High Risk340B Program
Mar 26, 2026
ILSB 3896Senate
Wholesale Drug Distribution Licensing Act (Senate)
Passed Senate 47-0; Arrived in HouseMedium RiskDrug Distribution
Mar 26, 2026
KYHB 388House
Prescription Drugs — Controlled Substances & KASPER
Delivered to Governor (Mar 26)High RiskControlled Substances
Mar 26, 2026
KYHB 2House
Medicaid Reform
Passed House 77-21; Reassigned to Senate Health ServicesHigh RiskInsurance / Coverage
Mar 26, 2026
KYSB 56Senate
Nonopioid Analgesics — Medicaid Utilization Controls
Passed Senate 35-0; In House, Floor Amendments FiledHigh RiskPBM Reform
Mar 26, 2026
ILHB 1443House
Prescription Drug Affordability Board
House Floor — 2nd Reading, Short DebateHigh RiskDrug Pricing
Mar 25, 2026
ILHB 5046House
Electronic Prescription Transfers
House Floor — 2nd Reading, Short DebateLow RiskElectronic Prescribing
Mar 25, 2026
ILHB 4243House
Retail Pharmacy On-Site Requirements
House Floor — 2nd Reading, Short DebateHigh RiskPharmacy Operations
Mar 25, 2026
ILSB 3764Senate
Controlled Substances — Schedule II 90-Day Supply
Postponed in Licensed Activities CommitteeMedium RiskControlled Substances
Mar 25, 2026
ILSB 3801Senate
Prescription Labeling (Senate)
Postponed in Executive CommitteeLow RiskPrescription Labeling
Mar 25, 2026
ILHB 4953House
Wholesale Drug Distribution — Delivery Restrictions
House Floor — 2nd Reading, Short DebateMedium RiskDrug Distribution
Mar 25, 2026
KYSB 65Senate
Deficient Administrative Regulations (Pharmacy/KASPER)
Delivered to Governor (Mar 25)High RiskPharmacy Operations
Mar 25, 2026
KYSB 77Senate
Ibogaine Research for Opioid Use Disorder
Passed Senate 35-2; 2nd Reading in HouseLow RiskControlled Substances
Mar 25, 2026
ILSB 3507Senate
Controlled Substances — PMP Schedule II & IV (Senate)
Senate Floor — 3rd ReadingMedium RiskControlled Substances
Mar 24, 2026
ILSB 3731Senate
First 2026 General Revisory Act
Senate Floor — 3rd ReadingLow RiskOmnibus / Technical
Mar 24, 2026
AZHB 2364House
Abortion-Inducing Drugs — Mail/Delivery Violations
Passed House 31-22; Senate JudiciaryHigh RiskControlled Substances
Mar 23, 2026
AZHB 2434House
Controlled Substances Prescription Monitoring Program (CSPMP)
Passed House 55-0; Senate HHSHigh RiskPDMP
Mar 23, 2026
AZHB 2697House
Expired Opioid Antagonists — Use and Dispensing
Passed House 51-2; Senate RAGEMedium RiskControlled Substances
Mar 23, 2026
AZHB 2733House
Pharmacy Board — Renewals and Ownership Change
Passed House 52-0; Senate HHSHigh RiskPharmacy Operations
Mar 23, 2026
AZSB 1710Senate
Pharmacy Benefits — Patient Steering Prohibition
Stalled in CommitteeHigh RiskPBM Reform
Mar 20, 2026
ILHB 4154House
Pharmacist Licensure Modernization
House Floor — 2nd Reading, Short DebateMedium RiskPharmacist Licensure
Mar 19, 2026
ILHB 5427House
Wholesale Drug Distribution Licensing Act
House Floor — 2nd Reading, Short DebateMedium RiskDrug Distribution
Mar 19, 2026
ILHB 5148House
Controlled Substances — PMP Schedule II & IV
House Floor — 2nd Reading, Short DebateMedium RiskControlled Substances
Mar 19, 2026
ILHB 4793House
Pharmacist Dispensing — Non-Pharmaceutical Devices
House Floor — 2nd Reading, Short DebateLow RiskScope of Practice
Mar 19, 2026
ILHB 5116House
Controlled Substances Act — Prescriber/Dispenser System
Assigned to Human Services CommitteeLow RiskControlled Substances
Mar 18, 2026
AZHB 2953House
Pharmacy Board — Civil Penalties
Passed House 57-0; Senate RAGEHigh RiskPharmacy Operations
Mar 16, 2026
AZSB 1545Senate
PBM Pharmacy Ownership Prohibition
Died in CommitteeHigh RiskPBM Reform
Mar 15, 2026
INHB 1277House
Long Term Care / Medicaid PathWays Reform
Enacted (HEA 1277)Medium RiskLong-Term Care
Mar 12, 2026
INSB 293Senate
Pharmacist Licensing Requirements
Enacted (Public Law 140)Medium RiskPharmacist Licensure
Mar 5, 2026
INSB 282Senate
Medical Spas and Drug Compounding Oversight
Enacted (SEA 282)High RiskCompounding / Medical Spas
Mar 5, 2026
INSB 262Senate
INSPECT Program (Prescription Drug Monitoring)
Enacted (SEA 262)Medium RiskPDMP
Mar 5, 2026
KYSB 38Senate
Reimbursements for Pharmacist Services
Passed Senate 37-0; In House Banking & InsuranceHigh RiskPrescription Access
Mar 5, 2026
KYHB 584House
Licensure Ban Removal for Controlled Substance Felons
Passed House 80-16; In Senate Committee on CommitteesMedium RiskPharmacist Licensure
Mar 5, 2026
KYHB 750House
Cychlorphine — New Controlled Substance
Referred to Judiciary (House)Low RiskControlled Substances
Mar 4, 2026
KYHB 729House
Jimmie's Law — Pharmaceutical Drug Safety
Referred to Licensing, Occupations & Admin Regs (House)High RiskCompounding / Medical Spas
Mar 4, 2026
KYHB 735House
Regulation of Pharmacists — Technical Correction
Referred to Licensing, Occupations & Admin Regs (House)Low RiskOmnibus / Technical
Mar 4, 2026
AZHB 2415House
Kratom Products — Narcotic Drug Classification
Passed House 36-17; Senate JudiciaryMedium RiskControlled Substances
Feb 26, 2026
KYSB 253Senate
Medicinal Cannabis — KASPER Integration
Referred to Committee on Committees (Senate)Medium RiskHemp / Cannabis
Feb 25, 2026
INSB 250Senate
Regulation of Hemp
Passed Senate; Died on House CalendarHigh RiskHemp / Cannabis
Feb 24, 2026
KYHB 646House
Pharmaceuticals to Intentionally Terminate Life
Referred to Judiciary (House)High RiskControlled Substances
Feb 23, 2026
KYSB 211Senate
Generic Drug and Biosimilar Coverage
Referred to Committee on Committees (Senate)Medium RiskDrug Pricing
Feb 19, 2026
ILSB 3421Senate
Physician Assistant Practice Act
Assigned to Licensed Activities CommitteeHigh RiskScope of Practice
Feb 17, 2026
KYSB 72Senate
Health Care Heroes Act — Conscience Protections
Passed Senate 28-5; In House Committee on CommitteesHigh RiskPrescription Access
Feb 17, 2026
AZHB 2196House
Pharmacists — Reimbursement Costs and Appeals
Pending House AppropriationsHigh RiskPBM Reform
Feb 16, 2026
AZHB 4036House
Bulk Drug Substances — GLP-1 Compounding Prohibitions
Died (Withdrawn from Committee)High RiskCompounding / Medical Spas
Feb 13, 2026
AZHB 4047House
Medical Spas — Licensure and Regulation
House 2nd Read; StalledHigh RiskCompounding / Medical Spas
Feb 11, 2026
ILHB 5327House
Prescription Labeling
Referred to Rules CommitteeLow RiskPrescription Labeling
Feb 10, 2026
ILSB 3146Senate
340B Drug Pricing Program Reporting Act
Assigned to Senate Executive CommitteeMedium Risk340B Program
Feb 10, 2026
KYSB 174Senate
Pharmacy Technician Supervision (Nonretail)
Referred to Committee on Committees (Senate)Medium RiskPharmacy Operations
Feb 10, 2026
AZHB 2965House
Covered Entities — 340B Drug Distribution
House 2nd Read; StalledHigh Risk340B Program
Feb 5, 2026
ILHB 4655House
Pharmacy — Refusal to Dispense
Referred to Rules CommitteeMedium RiskPharmacy Operations
Feb 3, 2026
AZSB 1542Senate
Controlled Substances — MDMA Research and Access
Referred to Senate PS&T; StalledMedium RiskControlled Substances
Feb 3, 2026
INSB 157Senate
Generic Drug Cost Disclosure
Passed Senate; Died in House CommitteeMedium RiskDrug Pricing
Jan 28, 2026
AZSB 1309Senate
Pharmacists — Care Standard and Prescriptions
Senate 2nd Read; StalledHigh RiskScope of Practice
Jan 28, 2026
AZHB 2569House
Terminally Ill Individuals — End-of-Life Decisions (Thomas M. Dow Act)
House 2nd Read; StalledHigh RiskScope of Practice
Jan 21, 2026
AZHB 2653House
Abortion Repeals
House 2nd Read; StalledMedium RiskScope of Practice
Jan 21, 2026
AZSB 1218Senate
Abortion Repeals (Senate)
Senate 2nd Read; StalledMedium RiskScope of Practice
Jan 21, 2026
KYSB 103Senate
Prescription Drug Cost-Sharing Limits
Referred to Committee on Committees (Senate)High RiskDrug Pricing
Jan 16, 2026
KYHB 153House
Medications for Substance Use Disorder
Referred to Health Services (House)Medium RiskControlled Substances
Jan 14, 2026
KYSB 82Senate
Medications for Substance Use Disorder (Senate)
Referred to Committee on Committees (Senate)Medium RiskControlled Substances
Jan 13, 2026
AZHB 2007House
Ivermectin — Over-the-Counter Drug
House 2nd Read; StalledMedium RiskPrescription Access
Jan 13, 2026
INSB 221Senate
Pharmacist Treatment by Standing Order
Referred to Committee (Session Adjourned)Medium RiskScope of Practice
Jan 8, 2026
INHB 1399House
Ephedrine and Pseudoephedrine Products
Referred to Committee (Session Adjourned)Low RiskControlled Substances
Jan 8, 2026
INHB 1129House
Advanced Practice Registered Nurses
Referred to Committee (Session Adjourned)High RiskScope of Practice
Jan 5, 2026
ILHB 1697Joint
Prescription Drug Affordability Act / PBM Reform
Enacted (PA 104-0027)High RiskPBM Reform
Jul 1, 2025
AZSB 1555Senate
Psilocybin — Conditional Rescheduling
Enacted (Chapter 231)Low RiskControlled Substances
Jun 27, 2025
AZSB 1702Senate
Hemp-Derived Products — Regulation
Died (Adjournment Without Final Passage)High RiskHemp / Cannabis
Jun 27, 2025
ILHR 0334House
Resolution: Eliminate MPJE Exam Requirement
Adopted (Non-Binding)Low RiskPharmacist Licensure
May 31, 2025
AZHB 2175House
Claims — Prior Authorization Medical Director Review
Enacted (Chapter 165)Medium RiskInsurance / Coverage
May 20, 2025
AZSB 1377Senate
Donated Medicine — Authorized Recipients and Immunity
Enacted (Chapter 139)Low RiskDrug Distribution
May 7, 2025
INSEA 140Joint
Pharmacy Benefit Manager Reform
Enacted (Public Law 189)High RiskPBM Reform
May 6, 2025
INHB 1604House
Copay Accumulator Restrictions
Enacted (Public Law 237)Medium RiskPrescription Access
May 6, 2025
AZHB 2405House
Topical Medications — Patient Take-Home
Enacted (Signed 2025)Low RiskPharmacy Operations
May 1, 2025
AZHB 2627House
Pharmacies — Emergency Authority
Enacted (Chapter 86)Medium RiskPharmacy Operations
Apr 18, 2025
AZHB 2628House
Pharmacists — Emergency Medication Administration
Enacted (Signed Apr 18, 2025)Medium RiskScope of Practice
Apr 18, 2025
AZSB 1214Senate
Pharmacists — Independent Testing and Treatment
Enacted (Signed Apr 15, 2025)High RiskScope of Practice
Apr 15, 2025
ILHB 1540House
Controlled Substances — Pharmacy ID Requirements
Passed House 108-2-3; Senate AssignmentsLow RiskControlled Substances
Apr 14, 2025
AZHB 2291House
Opioids — Red-Cap Labeling Requirement Repeal
Enacted (Chapter 45)Low RiskControlled Substances
Apr 7, 2025
AZSB 1102Senate
Pharmacy Benefits — Prescribing Exemption
Enacted (Chapter 5)High RiskPBM Reform
Mar 25, 2025
ILHB 3350House
Patient Access 340B Pharmacy
Re-referred to Rules Committee (Rule 19(a))Medium Risk340B Program
Mar 21, 2025
ILHB 3335House
Insurance Code — Weight Loss Drugs
Re-referred to Rules Committee (Rule 19(a))Medium RiskInsurance / Coverage
Mar 21, 2025
AZHB 2757House
Essential Drugs — Price Gouging Limits
Died in CommitteeHigh RiskDrug Pricing
Feb 20, 2025
AZHB 2208House
Pharmacists — Below-Cost Reimbursement Prohibition
Died (Stalled after Committee)High RiskPBM Reform
Feb 17, 2025
AZSB 1396Senate
Pharmacy Board — Omnibus Modernization
Died (Introduced Dead)Medium RiskOmnibus / Technical
Feb 4, 2025
AZHB 2429House
Pharmacy Benefits — Workers' Comp Networks
Died (Never Assigned to Committee)Low RiskPharmacy Operations
Jan 22, 2025